In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price target of £22.90. The company’s shares opened ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,488. ...

The logo itself has stirred up big talk ... Menus, keyboards, buttons, everything might now shimmer with that semi-transparent, depth-rich look inspired by Vision Pro. The goal? A more immersive, ...

GSK said last year the antibiotic succeeded in a late-stage trial and plans to seek approval in that indication as well. GSK scientists discovered the drug, which was developed in part through the ...